These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33027542)

  • 41. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
    Imran M; Shah MR; Ullah F; Ullah S; Elhissi AM; Nawaz W; Ahmad F; Sadiq A; Ali I
    Drug Deliv; 2016 Nov; 23(9):3653-3664. PubMed ID: 27886514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proniosomes: a novel drug carrier preparation.
    Hu C; Rhodes DG
    Int J Pharm; 1999 Aug; 185(1):23-35. PubMed ID: 10425362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.
    Nasr M
    AAPS PharmSciTech; 2010 Mar; 11(1):85-9. PubMed ID: 20058106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review on novel vesicular drug delivery: proniosomes.
    Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
    Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proniosomal powder of captopril: formulation and evaluation.
    Gupta A; Prajapati SK; Singh M; Balamurugan M
    Mol Pharm; 2007; 4(4):596-9. PubMed ID: 17472398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential application of nanovesicles (niosomes and liposomes) for fortification of functional beverages with Isoleucine-Proline-Proline: A comparative study with central composite design approach.
    Rezvani M; Hesari J; Peighambardoust SH; Manconi M; Hamishehkar H; Escribano-Ferrer E
    Food Chem; 2019 Sep; 293():368-377. PubMed ID: 31151624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
    Shaikh KS; Chellampillai B; Pawar AP
    Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
    Shete H; Patravale V
    Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proniosomes derived niosomes: recent advancements in drug delivery and targeting.
    Khatoon M; Shah KU; Din FU; Shah SU; Rehman AU; Dilawar N; Khan AN
    Drug Deliv; 2017; 24(sup1):56-69. PubMed ID: 29130758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M; Sammour OA; Hammad MA; Megrab NA
    Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design and development of multiple emulsion for enhancement of oral bioavailability of acyclovir.
    Paul S; Kumar A; Yedurkar P; Sawant K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1809-17. PubMed ID: 23281917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between milk fat globules and green tea catechins.
    Rashidinejad A; Birch EJ; Everett DW
    Food Chem; 2016 May; 199():347-55. PubMed ID: 26775981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Nematollahi MH
    Daru; 2018 Sep; 26(1):11-17. PubMed ID: 30159762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
    Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
    Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clotrimazole Loaded Ufosomes for Topical Delivery: Formulation Development and In-Vitro Studies.
    Bolla PK; Meraz CA; Rodriguez VA; Deaguero I; Singh M; Yellepeddi VK; Renukuntla J
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Technology overview and drug delivery application of proniosome.
    Ahmad MZ; Mohammed AA; Mokhtar Ibrahim M
    Pharm Dev Technol; 2017 May; 22(3):302-311. PubMed ID: 26794727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formulation, Characterization and
    Patel P; Barot T; Kulkarni P
    Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
    Youm I; Murowchick JB; Youan BB
    Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.